Björk, P., Björk, A., Vogl, T., Stenström, M., Liberg, D., Olsson, A., . . . Leanderson, T. (2009). Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides. Public Library of Science.

Björk, Per, Anders Björk, Thomas Vogl, Martin Stenström, David Liberg, Anders Olsson, Johannes Roth, Fredrik Ivars, and Tomas Leanderson. Identification of Human S100A9 As a Novel Target for Treatment of Autoimmune Disease Via Binding to Quinoline-3-Carboxamides. Public Library of Science, 2009.

Björk, Per, et al. Identification of Human S100A9 As a Novel Target for Treatment of Autoimmune Disease Via Binding to Quinoline-3-Carboxamides. Public Library of Science, 2009.